[go: up one dir, main page]

RU2006103299A - SOLID MEDICINAL FORM OF HEPATOPROTECTIVE ACTION - Google Patents

SOLID MEDICINAL FORM OF HEPATOPROTECTIVE ACTION Download PDF

Info

Publication number
RU2006103299A
RU2006103299A RU2006103299/15A RU2006103299A RU2006103299A RU 2006103299 A RU2006103299 A RU 2006103299A RU 2006103299/15 A RU2006103299/15 A RU 2006103299/15A RU 2006103299 A RU2006103299 A RU 2006103299A RU 2006103299 A RU2006103299 A RU 2006103299A
Authority
RU
Russia
Prior art keywords
dosage form
polyvinylpyrrolidone
solid dosage
mannitol
flavanolignans
Prior art date
Application number
RU2006103299/15A
Other languages
Russian (ru)
Other versions
RU2314797C2 (en
Inventor
Мераб Ревазович Кокеладзе (RU)
Мераб Ревазович Кокеладзе
Тимофей Георгиевич Кожока (RU)
Тимофей Георгиевич Кожока
Галина Евгеньевна Барышникова (RU)
Галина Евгеньевна Барышникова
Original Assignee
Закрытое акционерное общество "Канонфарма продакшн" (RU)
Закрытое Акционерное Общество "Канонфарма Продакшн"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое акционерное общество "Канонфарма продакшн" (RU), Закрытое Акционерное Общество "Канонфарма Продакшн" filed Critical Закрытое акционерное общество "Канонфарма продакшн" (RU)
Priority to RU2006103299/15A priority Critical patent/RU2314797C2/en
Publication of RU2006103299A publication Critical patent/RU2006103299A/en
Application granted granted Critical
Publication of RU2314797C2 publication Critical patent/RU2314797C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (4)

1. Твердая лекарственная форма гепатопротекторного действия, содержащая комбинацию флаванолигнанов с фосфолипидами и целевые добавки, такие как коллоидный диоксид кремния, отличающаяся тем, что дополнительно содержит поливинилпирролидон, трехалозу, стеарилфумарат натрия и фосфат кальция и/или маннит при следующем соотношении компонентов, мас.%:1. A solid dosage form of hepatoprotective action containing a combination of flavanolignans with phospholipids and target additives, such as colloidal silicon dioxide, characterized in that it further comprises polyvinylpyrrolidone, trialose, sodium stearyl fumarate and calcium phosphate and / or mannitol in the following ratio of components, wt.%. : ФосфолипидыPhospholipids 5-655-65 ФлаванолигнаныFlavanolignans 5-655-65 Коллоидный диоксид кремнияColloidal silicon dioxide 10-2010-20 ПоливинилпирролидонPolyvinylpyrrolidone 1-51-5 Стеарилфумарат натрияSodium Stearyl Fumarate 0,25-1,50.25-1.5 ТрехалозаTrehalose 1-51-5 Фосфат кальция и/или маннитCalcium Phosphate and / or Mannitol ОстальноеRest
2. Твердая лекарственная форма по п.1, отличающаяся тем, что в качестве компонента, содержащего флаванолигнаны, используется Силимар.2. The solid dosage form according to claim 1, characterized in that Silimar is used as a component containing flavanolignans. 3. Твердая лекарственная форма по п.1, отличающаяся тем, что в качестве поливинилпирролидона содержит Коллидон F-90 или Пласдон К-90.3. The solid dosage form according to claim 1, characterized in that as polyvinylpyrrolidone contains Collidone F-90 or Plasdon K-90. 4. Способ получения твердой лекарственной формы по п.1 в капсулах, который включает стадии увлажнения смеси фосфолипида с коллоидным диоксидом кремния небольшим количеством воды при массовом соотношении приблизительно 2:1 соответственно добавления флаванолигнана, фосфата кальция и/или маннита, трехалозы, увлажнения смеси 15% водным раствором поливинилпирролидона, влажного и сухого гранулирования, опудривания сухого гранулята стеарилфумаратом натрия.4. The method of producing a solid dosage form according to claim 1 in capsules, which comprises the steps of moistening a mixture of phospholipid with colloidal silicon dioxide with a small amount of water at a weight ratio of approximately 2: 1, respectively adding flavanolignan, calcium phosphate and / or mannitol, trialose, moistening the mixture 15 % aqueous solution of polyvinylpyrrolidone, wet and dry granulation, dusting of the dry granulate with sodium stearyl fumarate.
RU2006103299/15A 2006-02-07 2006-02-07 Solid medicinal formulation of hepatoprotective effect RU2314797C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2006103299/15A RU2314797C2 (en) 2006-02-07 2006-02-07 Solid medicinal formulation of hepatoprotective effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006103299/15A RU2314797C2 (en) 2006-02-07 2006-02-07 Solid medicinal formulation of hepatoprotective effect

Publications (2)

Publication Number Publication Date
RU2006103299A true RU2006103299A (en) 2007-08-27
RU2314797C2 RU2314797C2 (en) 2008-01-20

Family

ID=38596938

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006103299/15A RU2314797C2 (en) 2006-02-07 2006-02-07 Solid medicinal formulation of hepatoprotective effect

Country Status (1)

Country Link
RU (1) RU2314797C2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105816422B (en) 2015-01-05 2020-08-14 天士力医药集团股份有限公司 Silibinin injection and preparation method thereof
CN105983016B (en) 2015-03-23 2023-08-11 天士力医药集团股份有限公司 A pharmaceutical composition containing silybin
CN105983017A (en) 2015-03-23 2016-10-05 天士力制药集团股份有限公司 Medicine composition containing silibinin and L-carnitine

Also Published As

Publication number Publication date
RU2314797C2 (en) 2008-01-20

Similar Documents

Publication Publication Date Title
FI3984528T3 (en) Pharmaceutical compositions comprising nilotinib
ES2453477T3 (en) Composition of coprocessed excipient for a tablet, its preparation and use
HRP20120093T1 (en) Stable laquinimod preparations
RU2017134002A (en) STABLE TETRAHYDROBIOPTERIN COMPOSITIONS
KR101308897B1 (en) Effervescent composition including herbal extract
ES2332859B1 (en) PROCEDURE TO IMPROVE THE GENERAL STATE OF RUMINANTS.
RU2006103299A (en) SOLID MEDICINAL FORM OF HEPATOPROTECTIVE ACTION
RU2008115582A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PARKINSON'S DISEASE
RU2015141639A (en) COMBINED MEDICINAL FORM IN THE FORM OF EFFICIENT TABLETS AND METHOD FOR PRODUCING IT
RU2013130801A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DISEASES OF JOINT AND BONE TISSUES
RU2013139744A (en) ANTACID MEDICINAL PRODUCT AND METHODS FOR ITS OBTAINING (OPTIONS)
CN1489905A (en) Powdery disinfectant for sterilizing silk-worm body
RU2016105601A (en) PHARMACEUTICAL RECIPE OF MODIFIED RELEASE CONTAINING GLYCLASIDE, ORAL ORAL, AND METHOD FOR PREPARING IT
RU2006107239A (en) OIL LINE COLLECTOR STABILIZER
RU2007115551A (en) VACCINE AGAINST COLIBACTERIOSIS
RU2011139585A (en) BRUSHITE CEMENT FOR BONE SURGERY
RU2004138697A (en) AN ANTI-HYPERTENSIVE ACTION MEDICINAL PRODUCT AND METHOD FOR PRODUCING IT
RU2008132922A (en) METHOD FOR TREATING DAMAGES OF ORGANISM SYSTEMS DUE TO ACTIVATION OF THE PEROXIDATION PROCESS PROCESS AND THE LIQUID PHARMACEUTICAL COMPOSITION FOR ITS IMPLEMENTATION
RU2004118342A (en) FIRE EXTINGUISHING POWDER COMPOSITION
RU2021103296A (en) Means for preparing a therapeutic solution with a synergistic effect, a method for organizing means for preparing a therapeutic solution with a synergistic effect
RU2007106760A (en) The adjuvant composition for BIOLOGICAL protective action containing immunodominant antigens TISSUE helminths (ECHINOCOCCUS GRANULOSUS, ECHINOCOCCUS MULTILOCULARIS, TRICHINELLA SPIRALIS)
RU2003116915A (en) MEDICINAL FORM WITH ANTI-HYPERTENSIVE, COAST-EXPANDING, ANTIATHEROSCLEROTIC AND SPASMOLITIC ACTION, AND METHOD FOR PRODUCING IT
RU2283085C2 (en) Pharmaceutical composition for treatment of skin lesions
RU2006142336A (en) PHARMACEUTICAL COMPOSITION BASED ON LADASTEN
RU2015107685A (en) An immunostimulating pharmaceutical composition

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20170117